Search

Search Results

• 

  Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients

  S. Canestri, M.C. Totaro, E. Serone, B. Tolusso, D. Frezza, E. Gremese, G. Ferraccioli

  20-12-2012 Pages 368-373

  DOI https://doi.org/10.4081/reumatismo.2012.368

  • 2,826 abstract views
  • 1,011 PDF
• 

  Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents

  S.L. Bello, L. Serafino, C. Bonali, N. Terlizzi, C. Fanizza, C. Anecchino, G. Lapaldula

  11-12-2012 Pages 299-306

  DOI https://doi.org/10.4081/reumatismo.2012.299

  • 2,921 abstract views
  • 1,433 PDF
• 

  Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

  L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

  06-11-2014 Pages 224-232

  DOI https://doi.org/10.4081/reumatismo.2014.748

  • 2,814 abstract views
  • 1,775 PDF
• 

  Evaluation of the effect of rituximab on fatigue in rheumatoid arthritis using the Chalder Fatigue Scale

  Ilham Ben Marzouk, Imane El Binoune, Samira Rostom, Hajar Elallagui, Ikram Elmoubarik, Salma Zemrani, Bouchra Amine, Kaoutar Dib, Rachid Bahiri

  28-10-2026

  DOI https://doi.org/10.4081/reumatismo.2026.2412

  • 270 abstract views
  • 27 PDF
• 

  Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide

  M. Benucci, F. Li Gobbi, P. Panconesi, M. Manfredi, P. Sarzi-Puttini, F. Atzeni

  27-05-2013 Pages 90-94

  DOI https://doi.org/10.4081/reumatismo.2013.90

  • 3,490 abstract views
  • 1,069 PDF
• 

  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

  S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

  06-07-2018 Pages 78-84

  DOI https://doi.org/10.4081/reumatismo.2018.1011

  • 3,165 abstract views
  • 1,612 PDF
• 

  Successful treatment of refractory adult onset Still’s disease with rituximab

  N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman

  16-12-2016 Pages 159-162

  DOI https://doi.org/10.4081/reumatismo.2016.888

  • 3,454 abstract views
  • 1,577 PDF

• PO:15:216 | Safety and Efficacy of a single dose of Rituximab to manage Pregnancy-Related Severe Flare of Systemic Lupus Erythematosus: A Case Report

  Eugenio Capparelli¹, Daniela Bompane¹, Eleonora Zaccara¹, Laura Castelnovo¹, Antonio Tamburello¹, Antonino Mazzone², Paola Faggioli¹ | ¹UOC Reumatologia, ASST Ovest Milanese, Legnano, Milano, Italy; ²UOC Medicina Interna, ASST Ovest Milanese, Legnano, Milano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2329

  • 241 abstract views

• PO:33:203 | Efficacy and safety of rituximab in eosinophilic fasciitis: report of three cases and systematic literature review

  Andrea Benini¹, Beatrice Moccaldi¹, Marco Binda¹, Anna Cuberli¹, Mariangela Favaro¹, Andrea Doria¹, Elisabetta Zanatta¹ | ¹UOC Reumatologia, Azienda Ospedale, Università di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2210

  • 431 abstract views
• 

  Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa

  A.A. Akpabio, B.I. Otike-Odibi

  23-07-2020 Pages 115-119

  DOI https://doi.org/10.4081/reumatismo.2020.1274

  • 1,699 abstract views
  • 1,065 PDF
• 

  Are biological drugs safe in pregnancy?

  A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

  31-03-2015 Pages 304-317

  DOI https://doi.org/10.4081/reumatismo.2014.798

  • 4,410 abstract views
  • 2,795 PDF

• PO:24:068 | Case Report: ‘Spontaneous Pneumomediastinum in a Patient with MDA5-Positive Dermatomyositis and Severe Pulmonary Fibrosis’

  Carlotta Braga¹, Margherita Rizzo¹, Marta Raschellà¹, Beatrice Maranini¹, Gioacchino Schifino², Aldo Carnevale³, Marcello Govoni¹, Andrea Lo Monaco¹ | ¹Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna Ferrara, Italy; ²Respiratory Medicine Unit, Department of Cardio-Thoracic-Vascular Pathologies, Arcispedale Sant'Anna, Ferrara, Italy; ³Radiology Unit, Department of Translational Medicine, University of Ferrara, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2353

  • 186 abstract views

• CO:01:1 | Efficacy and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients

  Marco Lanzillotta¹, Jens Vikse², Elisabetta Goni³, Veronica Batani¹, Jasmin Mahajne¹, Lorenzo Dagna¹, Emanuel Della Torre¹. | ¹Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale San Raffaele, Milano, Italy; ²Department of Rheumatology, Stavanger University Hospital, Norway; ³Department of Medicine II, University Hospital, Ludwig Maximilian University, Munich, Germany

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.1961

  • 579 abstract views

• PO:26:087 | Rituximab versus glucocorticoids for IgG4-related disease: a European retrospective multi-center study of 167 patients

  Marco Lanzillotta¹, Jens Vikse², Elisabetta Goni³, Jasmin Mahajne¹, Veronica Batani¹, Lorenzo Dagna¹, Emanuel Della-Torre¹ | ¹Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale san Raffaele Milano, Italy; ²Department of Rheumatology, Stavanger University Hospital, Stavanger, Norway; ³Department of Medicine II, University Hospital, Ludwig Maximilian University Munich, Munich Germany

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2355

  • 267 abstract views

• Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)

  V. Bruzzese, J. Pepe

  Pages 306-308

  DOI https://doi.org/10.4081/reumatismo.2009.306

  • 1,220 abstract views
  • 974 PDF
• 

  Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

  Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

  07-04-2025

  DOI https://doi.org/10.4081/reumatismo.2025.1817

  • 2,924 abstract views
  • 1,486 PDF
  • 398 SUPPLEMENTARY MATERIAL
• 

  Acquired hemophilia A treated with rituximab in a 62-year-old female with rheumatoid arthritis: a case-based review

  D. Mohamadzadeh, S. Assar, F. Farsad

  19-12-2023

  DOI https://doi.org/10.4081/reumatismo.2023.1585

  • 2,031 abstract views
  • 654 PDF
• 

  Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission

  B. Cremonezi Lammoglia, L. de Aguiar Trevise, T. Paslar Leal, M. Pereira Lopes Vieira Pinto, G. Hasselmann, N. Salles Rosa Neto

  19-12-2023

  DOI https://doi.org/10.4081/reumatismo.2023.1588

  • 1,885 abstract views
  • 785 PDF

• PO:11:165 | Clinical mimicry and therapeutic challenge: A Case of Rapidly Progressive Mixed Connective Tissue Disease

  Elena Maria Di Virgilio¹, Elisabetta Chessa², Valentina Ibba², Cosimina Matulli², Jessica Sorgia¹, Andrea Pace¹, Matteo Piga^1|2, Alberto Cauli^1|2 | ¹Università degli studi di Cagliari-Reumatologia, Cagliari, Italy; ²Struttura complessa di Reumatologia- AOU Cagliari, Cagliari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2311

  • 253 abstract views

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  Pages 182-186

  DOI https://doi.org/10.4081/reumatismo.2009.182

  • 1,218 abstract views
  • 890 PDF
• 

  A short history of anti-rheumatic therapy - VII. Biological agents

  G. Pasero, P. Marson, B. Gatto

  09-11-2011 Pages 185-194

  DOI https://doi.org/10.4081/reumatismo.2011.185

  • 1,947 abstract views
  • 1,414 PDF

• PO:10:157 | Sjögren’s syndrome with cryoglobulinemia associated with POEMS syndrome

  Andrea Mazzon¹, Elena Bianchi¹, Virginia Berlengiero¹, Luca Cantarini¹, Bruno Frediani¹, Enrico Selvi¹ | ¹Azienda Ospedaliera Universitaria Senese Le Scotte, Siena, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2150

  • 343 abstract views
• 

  Polymyositis following varicella and mumps infection in adults: report of two cases

  F. Masini, K. Gjeloshi, E. Pinotti, R. Ferrara, C. Romano, G. Cuomo

  19-12-2023

  DOI https://doi.org/10.4081/reumatismo.2023.1562

  • 1,845 abstract views
  • 686 PDF

• PO:35:227 | Long-term renal and survival outcomes in microscopic polyangiitis: data from an observational monocentric cohort

  Roberta Prevedello¹, Federica Davanzo¹, Luca Iorio¹, Eleonora Fiorin¹, Marta Codirenzi¹, Roberto Padoan¹, Andrea Doria¹. | ¹Unità di Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova, Padova, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2089

  • 317 abstract views
• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  09-11-2011 Pages 155-164

  DOI https://doi.org/10.4081/reumatismo.2011.155

  • 3,087 abstract views
  • 1,838 PDF

• PO:36:242 | Bilateral central retinal artery occlusion as the first manifestation of eosinophilic granulomatosis with polyangiitis during benralizumab therapy

  Benedetta Fazzi¹, Elena Treppo¹, Lucia Finocchio², Maria Pillon¹, Luca Quartuccio¹ | ¹Clinica di Reumatologia, Dipartimento di Medicina, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine; ²SOC Oculistica, Presidio Ospedaliero Universitario Santa Maria della Misericordia, ASUFC, Udine, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2216

  • 289 abstract views

• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

  M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

  Pages 253-258

  DOI https://doi.org/10.4081/reumatismo.2010.253

  • 2,554 abstract views
  • 1,007 PDF

• PO:22:039 | A rare form of interstitial lung disease: granulomatous and lymphocytic interstitial lung disease

  Francesca Cozzini^1|2, Francesco Falco¹, Alberto Cavazza¹, Lucia Spaggiari³, Chiara Marvisi¹, Francesca Petrillo^1|2, Caterina Ricordi^1|2, Francesco Muratore^1|2, Fabio Brandolino¹, Ilaria Chiapparoli¹, Carlo Salvarani^1|2, Andreina Manfredi^1|2 | ¹IRCCS Policlinico San Matteo, UO di Reumatologia, Pavia; ²Università degli studi di Modena e Reggio Emilia, Modena, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2183

  • 289 abstract views

• PO:10:149 | Efficacy of anifrolumab in a case of systemic lupus erythematosus with pulmonary involvement

  Fabio Brandolino¹, Giulia Pazzola¹, Luca Ronzoni³, Andreina Teresa Manfredi^1|2, Carlo Salvarani^1|2 | ¹SC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia; ²Università di Modena e Reggio Emilia, Scuola di specializzazione in Reumatologia, Modena; ³SC Malattie dell'Apparato Respiratorio, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2146

  • 474 abstract views

• PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis

  Marco Capodiferro¹, Daniele Domanico¹, Angelica Napoletano¹, Giulia Righetti², Patrizia Suppressa², Vincenzo Venerito¹, Giuseppe Lopalco¹, Florenzo Iannone¹, Fabio Cacciapaglia^1|2 | ¹Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; ²Department of Medicine and Surgery, Miulli General Hospital Acquaviva delle Fonti - LUM University Casamassima Bari Acquaviva delle Fonti, Bari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2307

  • 161 abstract views

• PO:36:250 | Eosinophilic granulomatosis with polyangiitis associated to Alpha-1 Antitrypsin Deficiency: a land still unexplored

  Maria Grazia Malandra¹, Vacchi Caterina¹, Santoro Filippo¹, Cassone Giulia¹, Martina Orlandi¹, Stefania Cerri¹, Dilia Giuggioli¹ | ¹Università di Modena - Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; ²S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; ³Università di Modena e Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; ⁴S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; ⁵Università di Modena e Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; ⁶Università di Modena e Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; ⁷Università di Modena e Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2388

  • 127 abstract views

• PO:14:197 | Safety of biologic and conventional immunosuppressants in an Italian cohort of patients with systemic lupus erythematosus: a longitudinal analysis from the Lupus Italian Registry pharmacoepidemiologic study promoted by the Italian Society of Rheumatology

  Davide Rozza¹, Carlo Alberto Scirè^1|2, Paola Conigliaro³, Giacomo Emmi⁴, Laura Coladonato⁶, Salvatore Scarpato⁷, Luca Iaccarino⁸, Serena Guiducci⁹, Giulia Pazzola¹⁰, Francesca Romana Spinelli¹¹, Micol Frassi¹², Ilaria Cavazzana¹², Chiara Scirocco¹³, Valeria Orefice¹³, Immacolata Prevete¹³, Alessandra Bortoluzzi¹⁴, Marcello Govoni¹⁴, Elena Bartoloni¹⁵, Luca Moroni¹⁶, Giuseppe Alvise Ramirez¹⁶, Valentina Canti¹⁶, Giorgio Pettiti¹⁷, Maria Chiara Ditto¹⁸, Enrico Fusaro¹⁸, Marta Mosca¹⁹, Lorenzo Cavagna²⁰, Fabrizio Conti¹¹, Andrea Doria⁸, Gian Domenico Sebastiani¹³, Sperimentatori Gruppo Lire⁵ | ¹Centro Studi della Società Italiana di Reumatologia, Milano; ²Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca, Monza; ³Università di Roma Tor Vergata; ⁴Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste; ⁵https://redcap.reumatologia.it/surveys/?s=LWL7WJM4KHDR97CC; ⁶Dip di Medicina di Precisione e Rigenerativa e area Jonica, Bari; ⁷Azienda Sanitaria Locale ^ASL Salerno; ⁸Università degli Studi di Padova; ⁹SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; ¹⁰Arcispedale Santa Maria Nuova Reggio Emilia; ¹¹Università degli Studi di Roma La Sapienza; ¹²Spedali Civili di Brescia; ¹³Azienda Ospedaliera San Camillo Forlanini, Roma; ¹⁴Azienda Ospedaliera Universitaria Sant'Anna, Ferrara; ¹⁵SC Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia; ¹⁶IRCCS Ospedale San Raffaele, Milano; ¹⁷Azienda Ospedaliera S. Croce e Carle, Cuneo; ¹⁸AOU Citta' della Salute e della Scienza di Torino; ¹⁹AOU Santa Chiara, Pisa; ²⁰Università di Pavia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2158

  • 344 abstract views
• 

  Anti-N-methyl-d-aspartate receptor encephalitis: mimicker of lupus and multiple sclerosis

  N. Sanghavi, B. Ayesha

  19-12-2023

  DOI https://doi.org/10.4081/reumatismo.2023.1598

  • 2,494 abstract views
  • 806 PDF

• PO:37:268 | Antineutrophil cytoplasmic antibodies-associated vasculitis mimicking giant cell arteritis: a diagnostic dilemma

  Bruno Biasi¹, Elena Vanni¹, Marco De Pinto², Giulia Cassone², Dilia Giuggioli^1|2. | ¹Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Modena, Italy; ²Rheumatology Unit, Azienda Ospedaliera-Universitaria Policlinico di Modena, Modena, Italy, Modena, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2099

  • 333 abstract views

• B-cell depletion and primary Sjögren’s syndrome: is there a role for rituximab?

  F. Atzeni, P. Sarzi-Puttini

  Pages 87-88

  DOI https://doi.org/10.4081/reumatismo.2010.87

  • 1,505 abstract views
  • 813 PDF

• CO:12:2 | Circulating cell signatures of disease activity in ANCA-associated vasculitis using automated hematologic profiling analysis with Sysmex XN-9000®: preliminary results from a monocentric cohort

  Federica Davanzo¹, Luca Iorio¹, Veronica Davanzo², Michela Pelloso², Eleonora Fiorin¹, Roberta Prevedello¹, Francesca Tosato², Martina Montagnana³, Roberto Padoan¹, Andrea Doria¹ | ¹Rheumatology Unit, Department of Medicine DIMED, University of Padua Padova, Italy; ²Laboratory Medicine Unit, Biomedical Sciences Department-DSB, University of Padua Padova, Italy; ³Department of Medicine DIMED, University of Padua Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2280

  • 121 abstract views
• 

  Atypical adult polyarteritis nodosa unmasking deficiency of adenosine deaminase 2: a case report about the importance of genetic testing in adults

  Sofia Antolini, Denise Cassandrini, Sara Bindoli, Vincenzo Bronte, Angelo Fassio

  10-11-2026

  DOI https://doi.org/10.4081/reumatismo.2026.2408

  • 52 abstract views
  • 21 PDF
  • 4 SUPPLEMENTARY MATERIAL

• PO:36:252 | Long-Term Outcomes of Patients with Takayasu Arteritis in the Era of Biological Agents: a Multicenter International Study

  Alessandro Tomelleri¹, Durga Prasanna Misra², Fatma Alibaz-Oner³, Chiara Marvisi⁴, Chiara Calabrese¹, Upendra Rathore², Aysegul Avcu³, Adele Del Giudice⁴, Elisabetta Olivi⁴, Caterina Ricordi⁴, Corrado Campochiaro¹, Elena Baldissera¹, Marco Matucci-Cerinic¹, Haner Direskeneli³, Carlo Salvarani⁴, Lorenzo Dagna¹ | ¹IRCCS Ospedale San Raffaele, Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare Milano, Italy; ²Sanjay Gandhi Postgraduate Institute of Medical Sciences SGPGIMS, Clinical Immunology and Rheumatology Lucknow Country, India; ³Marmara University, School of Medicine, Department of Internal Medicine, Division of Rheumatology Istanbul, Turkey; ⁴Azienda USL-IRCCS di Reggio Emilia, Unità di Reumatologia Reggio Emilia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2389

  • 181 abstract views

• PO:11:171 | Subcutaneous tocilizumab use in a young-onset mixed connective tissue disease patient with multiple treatment failures

  Rhaysa Araujo Mousinho¹, Elide Lupi², Massimiliano Limonta² | ¹Clinica di Reumatologia, Dipartimento di Medicina and ²Istituto di Anatomia Patologica, Dipartimento di Medicina di Laboratorio, Osp. S. M. della Misericordia, Università di Udine, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2154

  • 370 abstract views

• CO:10:2 | Common variable immunodeficiency patients complicated by autoimmune and inflammatory rheumatic manifestations reveal high frequency of genetic variants potentially linked to inborn errors of immunity

  Paolo Semeraro¹, Micol Frassi¹, Silvia Clara Giliani², Franco Franceschini¹, Paolo Airò¹. | ¹Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili of Brescia and University of Brescia; ²Medical Genetic Laboratory, ASST Spedali Civili of Brescia and University of Brescia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.1991

  • 1,098 abstract views

• PO:06:086 | Updated Systematic Literature Review and meta-analysis to Inform the Italian Society of Rheumatology Recommendations on the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease

  Angelo Fassio¹, Marco Sebastiani^9|10, Francesco Pollastri¹, Chiara Crotti⁴, Nicola Ughi⁵, Enrico De Lorenzis⁶, Silvia Mancuso⁷, Massimo Radin⁸, Francesca Cozzini⁹, Greta Carrara¹¹, Gianpiero Landolfi¹¹, Roberto Rozza¹¹, Andreina Manfredi^2|3 | ¹Rheumatology Unit, University of Verona, Verona, Italy; ²University of Modena and Reggio Emilia, Reggio Emilia, Italy; ³Rheumatology Unit, AUSL-IRCCS, Reggio Emilia, Italy; ⁴Bone Disease Unit, Department of Rheumatology and Medical Science, ASST-G.Pini-CTO, Milan, Italy; ⁵Division of Rheumatology, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; ⁶Department of Aging Diseases, Orthopedic and Rheumatology, Rheumatology Division, P. Gemelli, Roma, Italy; ⁷Rheumatology Unit, Department of Clinical, Internal, Anaesthesiologic and Cardiovascular, Sciences, Sapienza, Roma, Italy; ⁸CMID, San Giovanni Bosco Hub Hospital ASL Città di Torino and Department of Clinical and Biological Sciences, Turin, Italy; ⁹Department of Medicine and Surgery, University of Parma, Parma, Italy; ¹⁰Rheumatology Unit, AUSL Piacenza, Piacenza, Italy; ¹¹Unità Epidemiologica, SIR, Società Italiana di Reumatologia, Milano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2299

  • 240 abstract views

• PO:30:160 | A rare case of juvenile systemic sclerosis

  Marta Arese^1|2, Francesco Baldo³, Stefania Costi³, Achille Marino³, Cecilia Chighizola^1|3, Roberto Felice Caporali^1|2 | ¹Azienda Ospedaliera Universitaria Senese, Università degli Studi di Siena; ²Reumatologia Clinica, ASST Gaetano Pini-CTO, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2203

  • 402 abstract views

• PO:11:167 | Subtle symptoms masking a challenging diagnosis: a clinical case of intestinal vasculitis in systemic lupus erythematosus

  Ilaria Pace¹, Giulia Rizzo¹, Elisabetta Chessa², Davide Corradini¹, Roberta Origa¹, Valentina Ibba², Alberto Floris^1|2, Alberto Cauli^1|2, Matteo Piga^1|2 | ¹Sapienza Università di Roma; ²SC Reumatologia, AOU Cagliari, Cagliari, Italy 

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2153

  • 761 abstract views

• PO:25:085 | Anti-MDA5 antibody syndrome, a life-threatening condition for rheumatologist and pulmonologist A case series

  Francesca Cozzini^1|2, Cecilia Burattini¹, Elena Bravi¹, Chiara Nani¹, Eugenio Arrigoni¹, Fabia Cavallotti¹, Ilaria Platè¹, Marco Sebastiani^1|3 | ¹Ospedale Guglielmo da Saliceto Piacenza, Italy; ²Università degli studi di Modena e Reggio Emilia, Italy; ³Università degli Studi di Parma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2354

  • 193 abstract views

• CO:10:3 | Clinical response to JAK inhibitors or non-TNFi-targeted biologicals according to synovial tissue characteristics in patients with difficult-to-treat rheumatoid arthritis

  Mariangela Salvato¹, Alessandro Giollo¹, Francesca Frizzera¹, Kiren Khalid¹, Lorenzo Di Luozzo¹, Maria Capita¹, Marianna Tamussin¹, Carlo Garaffoni², Marny Fedrigo³, Annalisa Angelini³, Ettore Silvagni², Andrea Doria¹. | ¹Rheumatology Unit, Department of Medicine - DIMED, University of Padova; ²Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna; ³Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.1992

  • 376 abstract views

• PO:32:176 | Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease: results from a European Scleroderma Trials and Research cohort study

  Devis Benfaremo¹, Corrado Campochiaro², Gábor Kumánovics³, Christina Bergmann⁴, Elisabetta Zanatta⁵, David Launay⁶, Serena Guiducci⁷, Mickael Martin⁸, Carolina De Souza Müller⁹, Carlomaurizio Montecucco¹⁰, Luc Mouthon¹¹, Gabriella Szucs¹², Kastriot Kastrati¹³, Marie-Elise Truchetet¹⁴, Madelon Vonk¹⁵, Francesco Del Galdo¹⁶, Marco Matucci-Cerinic², Gianluca Moroncini¹, Yannick Allanore¹⁷. | ¹Department of Clinical and Molecular Sciences, Marche Polytechnic University, Marche University Hospital, Ancona, Italy; ²Vita-Salute San Raffaele University, San Raffaele Hospital, Milano, Italy; ³University of Pécs, Department Of Rheumatology And Immunology, Pécs, Hungary; ⁴University Hospital Erlangen, Department Internal Medicine 3, Erlangen, Germany; ⁵Padova University Hospital, Rheumatology Unit, Padova, Italy; ⁶Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Lille, France; ⁷University of Florence, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy; ⁸Poitiers University Hospital, Department of Internal Medicine Poitiers France; ⁹Hospital de Clinicas da Universidade Federal do Parana Curitiba Brazil; ¹⁰Università di Pavia e IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy; ¹¹Hôpital Cochin, Department of Internal Medicine, Paris, France; ¹²University of Debrecen, Faculty of Medicine, Department of Rheumatology, Debrecen, Hungary; ¹³Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria; ¹⁴CHU de Bordeaux, Rheumatology department, Bordeaux, France; ¹⁵Radboudumc, Department of Rheumatology Nijmegen The Netherlands; ¹⁶Leeds Raynauds and Scleroderma Program, NIHR Biomedical Research Centre, Leeds, United Kingdom; ¹⁷Université Paris Cité, Cochin Hospital, Rheumatology Department, Paris, France.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2077

  • 429 abstract views
• 

  Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement

  Sara Ferrigno, Immacolata Prevete, Valeria Orefice, Chiara Scirocco, Gian Domenico Sebastiani

  08-04-2026

  DOI https://doi.org/10.4081/reumatismo.2026.1956

  • 3,390 abstract views
  • 370 PDF

• PO:18:264 | Anifrolumab in Systemic Lupus Erythematosus: Bridging Clinical Trial Data with Real-World Evidence

  Giulia Cassone², Filippo Santoro¹, Caterina Vacchi², Dilia Giuggioli², Chiara Cabassi¹ | ¹UOC Reumatologia, AOU Policlinico di Modena, Università degli studi di Modena e Reggio Emilia Modena e Reggio Emilia, Italy; ²UOC Reumatologia, AOU Policlinico di Modena Modena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2337

  • 245 abstract views

• PO:25:079 | Anifrolumab in refractory dermatomyositis: a case report

  Chiara Calabrese¹, Corrado Campochiaro^1|2, Giacomo De Luca ^1|2, Veronica Batani¹, Marco Matucci-Cerinic^1|2, Lorenzo Dagna ^1|2 | ¹Dipartimento di Reumatologia e Scienze Mediche, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO Milano; ²Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico-Chirurgica e Trapianti, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2190

  • 351 abstract views

• PO:24:063 | Interstitial lung disease in idiopathic inflammatory myopathy patients: efficacy and safety of nintedanib

  Giulia Buonsante^1|2|3, Giacomo De Luca^1|2|3, Veronica Batani^1|2, Lorenzo Dagna^1|2|3, Marco Matucci-Cerinic^1|2|3, Corrado Campochiaro^1|2|3 | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital Milano, Italy; ²Inflammation, Fibrosis and aging Initiative INFLAGE, IRCCS San Raffaele Hospital Milano, Italy; ³Vita-Salute San Raffaele University, Milano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2350

  • 229 abstract views